A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Our Company We are a global leader in biosimulation science, technology, and consulting services for using Model-Informed Drug Development (“MIDD”) in the global biopharmaceutical and biotech industry. MIDD is an approach that utilizes biological and statistical models derived from preclinical, clinical, and evidence data to inform decision-making in drug research and development, and commercialization. Biosimulation is a critical component of MIDD that uses computer-aided mathematical simulation of biological processes and systems to understand the action of a drug in a human body or a population of humans. Biosimulation and hereby MIDD can increase the probability of success in bringing a new drug to market, accelerate its development and decrease the costs of drug development.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 419M | 419M | 385M | 354M | 336M | 286M |
| Net Income | -1.6M | -1.6M | -12M | -55M | 15M | -13M |
| EPS | $-0.01 | $-0.01 | $-0.08 | $-0.35 | $0.09 | $-0.09 |
| Free Cash Flow | 95M | 95M | 79M | 81M | 91M | 59M |
| ROIC | -0.4% | 1.1% | -0.2% | -4.1% | 2.2% | 1.3% |
| Gross Margin | 61.5% | 61.5% | 59.9% | 60.2% | 60.5% | 61.0% |
| Debt/Equity | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 | 0.30 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | 21M | 21M | -1.7M | -41M | 33M | 14M |
| Operating Margin | 5.0% | 5.0% | -0.4% | -11.5% | 9.7% | 4.7% |
| ROE | -0.2% | -0.2% | -1.1% | -5.2% | 1.4% | -1.4% |
| Shares Outstanding | 160M | 160M | 151M | 158M | 164M | 147M |
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 209M | 244M | 286M | 336M | 354M | 385M | 419M | 419M |
| Gross Margin | 61.7% | 58.6% | 61.0% | 60.5% | 60.2% | 59.9% | 61.5% | 61.5% |
| R&D | 12M | 20M | 20M | 28M | 34M | 37M | 41M | 41M |
| SG&A | 48M | 88M | 80M | 72M | 95M | 94M | 85M | 85M |
| EBIT | 20M | -24M | 14M | 33M | -41M | -1.7M | 21M | 21M |
| Op. Margin | 9.4% | -10.0% | 4.7% | 9.7% | -11.5% | -0.4% | 5.0% | 5.0% |
| Net Income | -8.9M | -49M | -13M | 15M | -55M | -12M | -1.6M | -1.6M |
| Net Margin | -4.3% | -20.3% | -4.6% | 4.4% | -15.6% | -3.1% | -0.4% | -0.4% |
| Non-Recurring | -113K | -19K | -351K | -169K | 47M | 0 | 0 | 0 |
| Returns on Capital | ||||||||
| ROIC | 8.1% | -6.1% | 1.3% | 2.2% | -4.1% | -0.2% | 1.1% | -0.4% |
| ROE | -3.4% | -7.5% | -1.4% | 1.4% | -5.2% | -1.1% | -0.2% | -0.2% |
| ROA | -22.9% | -7.6% | -1.0% | 1.0% | -3.5% | -0.8% | -0.1% | -0.1% |
| Cash Flow | ||||||||
| Op. Cash Flow | 38M | 45M | 60M | 93M | 83M | 80M | 96M | 96M |
| Free Cash Flow | 36M | 44M | 59M | 91M | 81M | 79M | 95M | 95M |
| Owner Earnings | 34M | -22M | 29M | 60M | -1.6M | -22M | -12M | -12M |
| CapEx | 2.1M | 863K | 1.1M | 1.4M | 1.8M | 1.6M | 1.8M | 1.8M |
| Maint. CapEx | 2.6M | 2.4M | 2.1M | 1.7M | 56M | 68M | 75M | 75M |
| Growth CapEx | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| D&A | 2.6M | 2.4M | 2.1M | 1.7M | 56M | 68M | 75M | 75M |
| CapEx/OCF | N/A | 1.9% | 1.9% | 1.5% | 2.1% | 2.0% | 1.8% | 1.8% |
| Capital Allocation | ||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 703K | 1.1M | 1.1M | 1.1M | 0 | 0 | 43M | 43M |
| Buyback Yield | N/A | 0.0% | N/A | N/A | N/A | N/A | 3.0% | 4.6% |
| Stock-Based Comp | 1.7M | 65M | 29M | 30M | 28M | 35M | 33M | 33M |
| Debt Repayment | 3.4M | 104M | 4.0M | 3.3M | 3.0M | 2.3M | 3.0M | 3.0M |
| Balance Sheet | ||||||||
| Net Debt | -26M | 27M | 122M | 72M | 68M | 133M | 116M | 116M |
| Cash & Equiv. | 29M | 271M | 186M | 237M | 235M | 179M | 189M | 189M |
| Long-Term Debt | 3.4M | 294M | 292M | 290M | 288M | 292M | 290M | 290M |
| Debt/Equity | 0.12 | 0.36 | 0.30 | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 |
| Interest Coverage | 0.7 | -1.0 | 0.8 | 1.8 | -1.8 | -0.1 | 1.1 | 1.1 |
| Equity | 29M | 822M | 1.0B | 1.1B | 1.0B | 1.1B | 1.1B | 1.1B |
| Total Assets | 39M | 1.3B | 1.5B | 1.6B | 1.6B | 1.6B | 1.6B | 1.6B |
| Total Liabilities | 10M | 447M | 470M | 493M | 516M | 516M | 494M | 494M |
| Intangibles | N/A | 396M | 512M | 487M | 487M | 485M | 447M | 447M |
| Retained Earnings | N/A | -62M | -76M | -61M | -116M | -128M | -130M | -130M |
| Working Capital | N/A | 271M | 183M | 239M | 210M | 165M | 162M | 162M |
| Current Assets | N/A | 347M | 275M | 342M | 340M | 311M | 315M | 315M |
| Current Liabilities | N/A | 75M | 92M | 103M | 130M | 146M | 153M | 153M |
| Per Share Data | ||||||||
| EPS | -0.07 | -0.37 | -0.09 | 0.09 | -0.35 | -0.08 | -0.01 | -0.01 |
| Owner EPS | 0.26 | -0.17 | 0.20 | 0.37 | -0.01 | -0.15 | -0.07 | -0.07 |
| Book Value | 0.23 | 6.16 | 7.07 | 6.60 | 6.62 | 7.03 | 6.66 | 6.66 |
| Cash Flow/Share | 0.30 | 0.34 | 0.41 | 0.57 | 0.52 | 0.53 | 0.60 | 0.46 |
| Dividends/Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 127.5M | 133.5M | 147.4M | 163.7M | 158.2M | 150.6M | 159.5M | 159.5M |
| Valuation | ||||||||
| P/E Ratio | N/A | N/A | N/A | 174.1 | N/A | N/A | N/A | -579.0 |
| P/FCF | N/A | 114.0 | 71.6 | 28.1 | 35.0 | 20.4 | 15.0 | 9.8 |
| EV/EBIT | N/A | N/A | 320.3 | 80.6 | N/A | N/A | 63.5 | 49.5 |
| Price/Book | N/A | 6.1 | 4.1 | 2.4 | 2.7 | 1.5 | 1.3 | 0.9 |
| Price/Sales | N/A | 20.4 | 16.1 | 9.4 | 8.1 | 5.6 | 4.3 | 2.2 |
| FCF Yield | N/A | 0.9% | 1.4% | 3.6% | 2.9% | 4.9% | 6.7% | 10.2% |
| Market Cap | N/A | 5.0B | 4.2B | 2.6B | 2.8B | 1.6B | 1.4B | 924M |
| Avg. Price | N/A | 37.29 | 31.30 | 19.33 | 18.04 | 14.44 | 11.31 | 5.79 |
| Year-End Price | N/A | 37.54 | 28.77 | 15.67 | 17.90 | 10.69 | 8.89 | 5.79 |
Certara, Inc. passes 4 of 9 quality checks, suggesting mixed fundamentals.
On a free-cash-flow basis, the stock trades at 9.7x vs a median of 28.1x. The company's 5-year average ROIC is 0.1% with a gross margin of 60.6%. Total shareholder yield (buybacks) is 4.6%. At current prices, the estimated annualized return to fair value is +9.7%.
Certara, Inc. (CERT) has a 5-year average return on invested capital (ROIC) of 0.1%. This is below average and may indicate limited pricing power.
Certara, Inc. (CERT) has a market capitalization of $924M. It is classified as a small-cap stock.
Certara, Inc. (CERT) does not currently pay a regular dividend. However, the company returns capital to shareholders through share buybacks, with a buyback yield of 4.61%.
Certara, Inc. (CERT) operates in the Services-Prepackaged Software industry, within the Technology sector.
Certara, Inc. (CERT) reported annual revenue of $419 million in its most recent fiscal year, based on SEC EDGAR filings.
Certara, Inc. (CERT) has a net profit margin of -0.4%. The company is currently unprofitable.
Certara, Inc. (CERT) generated $95 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
Certara, Inc. (CERT) has a debt-to-equity ratio of 0.29. This indicates a conservatively financed balance sheet.
Certara, Inc. (CERT) reported earnings per share (EPS) of $-0.01 in its most recent fiscal year.
Certara, Inc. (CERT) has a return on equity (ROE) of -0.2%. A negative ROE may indicate losses or negative equity.
Certara, Inc. (CERT) has a 5-year average gross margin of 60.6%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 7 years of financial data for Certara, Inc. (CERT), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Certara, Inc. (CERT) has a book value per share of $6.66, based on its most recent annual SEC filing.
No recent press releases.